Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
Journal Article
|Research
2023-12-05 • Pediatric Blood & Cancer
2023-12-05 • Pediatric Blood & Cancer
BACKGROUND/OBJECTIVES
High‐risk Hodgkin lymphoma (HRHL) in children is curable with combined modality therapy. The Association of Pediatric Hematology‐Oncology of Central America (AH...
High‐risk Hodgkin lymphoma (HRHL) in children is curable with combined modality therapy. The Association of Pediatric Hematology‐Oncology of Central America (AH...
Journal Article
|Research
2023-10-30 • Frontiers in Oncology
2023-10-30 • Frontiers in Oncology
INTRODUCTION
Acute Lymphoblastic Leukemia (ALL) is the most common pediatric malignancy. While the survival rate for childhood ALL exceeds 90% in high-income countries, the estimated...
Acute Lymphoblastic Leukemia (ALL) is the most common pediatric malignancy. While the survival rate for childhood ALL exceeds 90% in high-income countries, the estimated...
Journal Article
|Research
2023-08-03 • JCO Global Oncology
2023-08-03 • JCO Global Oncology
PURPOSE
Early integration of pediatric palliative care (PPC) for children with cancer is critical to improving the quality of life of both the patient and family. Understanding physi...
Early integration of pediatric palliative care (PPC) for children with cancer is critical to improving the quality of life of both the patient and family. Understanding physi...